SPI Scheme 2025: The Complete MSME Guide
How to Apply for SPI Scheme & Unlock Subsidy Faster
India’s pharmaceutical industry is powerful… but staying globally competitive requires constant quality upgrades, R&D investment, and compliance with WHO-GMP and Schedule M.
To support this transition, the Government of India introduced the Strengthening of Pharmaceuticals Industry (SPI) scheme, revamped in 2025, a massive opportunity for MSMEs and pharma clusters.
What Is the SPI Scheme?
The SPI scheme combines three major programs to improve pharma quality, strengthen clusters, and help MSMEs upgrade for export markets.
1️. APICF - Assistance to Pharmaceutical Industry for Common Facilities
Supports creation of:
- R&D labs
- Testing labs
- CETPs
- Logistics hubs
- Training centers
Subsidy:
- Up to 70% (or 90% in NE & Himalayan states)
- Max ₹20 crore per cluster
- Beneficiaries: SPVs, state-supported pharma clusters
2️. RPTUAS - Technology Upgradation Support
Designed for MSME pharma units upgrading to Revised Schedule M or WHO-GMP.
Supports:
- Clean rooms
- QC labs, stability chambers
- HVAC, water, steam utilities
- ETP & waste systems
- Certification expenses
Subsidy:
- 20% for turnover 150 crore
- 15% for 50-250 crore
- 10% for 250-500 crore
3️. PMPDS - Awareness, Studies & Promotion
Funds:
- Pharma events
- Industrial surveys
- Skill building
- Global branding opportunities
This builds visibility and industry growth.
Key Benefits of SPI Scheme 2025
- Subsidies for WHO-GMP & Schedule M upgrades
- Funding for cluster-level infrastructure
- Compliance support
- Reduced operational cost
- Better export competitiveness
- Trained workforce availability
For MSMEs, it’s a chance to grow faster with less financial pressure.
Learn more: https://finraja.com/strengthening-of-pharmaceuticals-industry-spi-scheme/